Molecular Profiling and Targeted Therapy for Advanced Thoracic Malignancies: A Biomarker-Derived, Multiarm, Multihistology Phase II Basket Trial

Abstract

This basket trial design was not feasible for many of the arms with rare mutations, but it allowed the study of the genetics of less common malignancies.